REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium,...

Related Keywords

Germany ,California ,United States ,Rockville ,Irvine ,Brazil ,Roberto Giugliani ,Porto Alegre ,Dana Cormack ,Raymond Wang ,Chris Brinzey ,University Of California ,Technology Platform ,Technology Platform Licensees ,Division Of Metabolic Disorders ,Nasdaq ,Program For The Study Of Neurodevelopment ,Genetics Service ,Corporate Communications ,Department Of Pediatrics ,Department Of Genetics ,Inborn Errors ,Metabolism Annual Symposium ,Mucopolysaccharidosis Type ,Hunter Syndrome ,Medical Genetics Service ,Metabolic Disorders ,Natural History ,Neuronopathic Mucopolysaccharidosis Type ,Mullen Scales ,Early Learning ,Language Developmental ,Maria Escolar ,Rare Disorders ,Platform Licensees ,Regenxbio Inc ,